bupropion

Product NDC
71335-1622
11-digit product format
713351622
Labeler code
71335
Product ID
71335-1622_4b83f9e5-854b-4eeb-a409-9e6ee4b6efd5
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
bupropion hydrochloride
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Labeler
Bryant Ranch Prepack
Application
ANDA202304
Marketing category
ANDA
Marketing start
2014-11-01
Marketing end
0000-00-00
Substance
BUPROPION HYDROCHLORIDE
Active strength
150 mg/1
Pharmacologic classes
Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
71335-1622-17133516220160 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1622-1) 2022-02-140000-00-00NoNoCurrent
71335-1622-27133516220290 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1622-2) 2022-06-300000-00-00NoNoCurrent
71335-1622-37133516220330 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1622-3) 2022-02-140000-00-00NoNoCurrent
71335-1622-471335162204120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1622-4) 2022-06-300000-00-00NoNoCurrent
71335-1622-57133516220545 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1622-5) 2022-06-300000-00-00NoNoCurrent
71335-1622-671335162206180 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1622-6) 2022-06-300000-00-00NoNoCurrent
71335-1622-77133516220728 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1622-7) 2022-06-300000-00-00NoNoCurrent
71335-1622-87133516220856 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1622-8) 2022-02-140000-00-00NoNoCurrent
71335-1622-971335162209100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1622-9) 2022-06-300000-00-00NoNoCurrent